US4618741098
US4618741098
eXoZymes Inc.
Loading chart...
Company Profile
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Latest News

ACCESS Newswire • 09/08/2026
eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT

ACCESS Newswire • 08/24/2026
Investor Summit | MicroCap Opportunities to Watch - August 26
GuruFocus.com • 08/22/2026
EXoZymes Inc (EXOZ) (Q2 2026) Earnings Call Highlights: Strategic Pivot and 10x Productivity ...

MarketBeat • 08/20/2026
eXoZymes Q2 Earnings Call Highlights
ACCESS Newswire • 08/20/2026
eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET Today
Related stocks
Key Metrics & Overview
Detailed metrics & financial data of the company
Company Profile
5
MetricsCountry
Region
Sector
Industry
Website
🛡️ Risk & Structural Analysis
Multi-Factor Risk Model & Market Data
7/7 Very High
3Y Volatility
-
Max Drawdown (3Y)
-
Sharpe Ratio (3Y)
-
Size Class
Micro Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections